MRI or risk calculator for suspected prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial compares using an upfront MRI versus a risk calculator to decide who needs a prostate biopsy. It may help men with suspected localized prostate cancer avoid unnecessary biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have more than 10 years of life expectancy left
- You have signs or symptoms pointing to localized prostate cancer
- Your doctor found something suspicious during a digital rectal exam (stage cT2)
- Your PSA level is between 3 and 20 ng/ml
- You have never been diagnosed with prostate cancer before
- You have no medical reason that would make an MRI or prostate biopsy unsafe, and you are not taking medications that affect PSA levels
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing an approach to find prostate cancer earlier in men who may be at higher risk. If you fit the criteria, you may get an mpMRI scan before undergoing a prostate biopsy to check for cancer.
This study uses MRI scans and artificial intelligence to predict the risk of clinically significant prostate cancer. It may help find a way to detect aggressive cancers without needing a biopsy.
This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.
This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.
This study uses a genetic risk score and a special MRI scan to find prostate cancers that are more likely to be dangerous. It aims to see if combining these tests can better identify which men need a biopsy.
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.